Is nisoldipine capable of reducing left ventricular preload?

Area of Science:

• Cardiology
• Pharmacology
• Physiology

Background:

• Calcium channel blockers are crucial in managing cardiovascular conditions.
• Nisoldipine, a dihydropyridine calcium channel blocker, is structurally similar to nifedipine.
• Understanding the hemodynamic effects of nisoldipine is essential for its clinical application.

Purpose of the Study:

• To investigate the effects of nisoldipine on cardiac function and hemodynamics in an animal model.
• To assess the impact of nisoldipine on left ventricular systolic pressure, systemic vascular resistance, and cardiac output.
• To determine if nisoldipine affects myocardial contractility and ventricular filling pressures.

Main Methods:

• The study involved ten anesthetized pigs.
• Nisoldipine was administered at a dose of 2-4 micrograms x kg-1 x min-1.
• Hemodynamic parameters including left ventricular pressure, cardiac output, and vascular resistance were monitored.

Main Results:

• Nisoldipine significantly reduced left ventricular systolic pressure by 40% and systemic vascular resistance by 35%.
• Maximal left ventricular dP/dt decreased by 20%, indicating reduced contractility, while cardiac output remained unchanged.
• Left ventricular end-diastolic volume and pressure decreased by 15% and 40%, respectively, with a slight increase in ejection fraction (13%).

Conclusions:

• Nisoldipine effectively reduces both preload (left ventricular end-diastolic volume and pressure) and afterload (systemic vascular resistance) in the heart.
• The drug achieves these effects without depressing myocardial contractility, suggesting a favorable profile for improving left ventricular efficiency.
• Nisoldipine promotes more efficient emptying of the left ventricle, highlighting its potential therapeutic value in cardiovascular medicine.